JP4330878B2 - 炎症性疾患の処置及び創傷治癒過程における補助療法のためのブロメラインの使用 - Google Patents
炎症性疾患の処置及び創傷治癒過程における補助療法のためのブロメラインの使用 Download PDFInfo
- Publication number
- JP4330878B2 JP4330878B2 JP2002545725A JP2002545725A JP4330878B2 JP 4330878 B2 JP4330878 B2 JP 4330878B2 JP 2002545725 A JP2002545725 A JP 2002545725A JP 2002545725 A JP2002545725 A JP 2002545725A JP 4330878 B2 JP4330878 B2 JP 4330878B2
- Authority
- JP
- Japan
- Prior art keywords
- bromelain
- treatment
- wound healing
- inflammatory diseases
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
ブロメラインBP及び熱不活化ブロメラインの、好中球からのIL−8の分泌に対する効果
ブロメラインベースパウダー(base powder)(BP)
ブロメラインBP(CPC Wolfgang Muehlbauer GmbH, Hamburg, Germanyより購入)を水に溶解し、凍結乾燥した。タンパク質分解活性及びタンパク質含量を、それぞれ、基質L−Pyr−Phe−Leu−pNA(Harrach et al., J Protein Chem 14(1995)41-52)及びバイオラドプロテインアッセイ(Bio-Rad Protein Assay)(Bio-Rad Laboratories GmbH, Muenchen, Germany)を使用することにより決定した。ブロメラインBPは、0.34U/mgである比活性を示した。ブロメラインBP溶液を80℃で1時間、加熱することにより、プロテアーゼ活性を破壊した。
好中球は、Ferranteら(J. Immunol. Methods. 36(1980)109)によって記載されているような一段階法によって単離した。
無細胞上清中のIL−8を、サンドイッチ酵素イムノアッセイ技術(R&D Systems, Minneapolis, USA)を使用して、定量した。2×105個の好中球を、96ウェルのマイクロタイタープレート内で、被検物質と共に、又は被検物質なしで、37℃でインキュベートした。24時間のインキュベーションの後、細胞を遠心分離(400×g、7分)し、無細胞上清を使用した。試料及び標品を、IL−8モノクローナル抗体でプレコーティングされたウェルへピペットで移し、室温で2.5時間インキュベートした。次いで、細胞を洗浄し、基質溶液を添加した。発色を停止させ、マイクロタイタープレートリーダー(SLT Labinstruments, Austria)を使用して測定した。
処理群と対照群との間の統計的有意性を、マンホイトニー−ウィルコクソン(Mann-Whitney-Wilcoxon)の検定、及びコンピュータープログラムインスタット(Instat)を使用して計算した。
ブロメラインBP及び熱不活化ブロメラインを、好中球におけるIL−8の分泌を増加させる能力に関して試験した。
Claims (4)
- 創傷治癒過程における補助療法のための医薬の製造のための、加熱処理によりそのプロテアーゼ活性が破壊されたブロメラインの使用。
- 医薬が炎症性疾患の処置のために設計されたものである、請求項1に記載の使用。
- 炎症性疾患が、乾癬、慢性関節リウマチ、もしくは多発関節炎、又はアレルギーに関連している、請求項2に記載の使用。
- 医薬が抗ヒスタミン薬である、請求項1に記載の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00125986.0A EP1208849B1 (en) | 2000-11-28 | 2000-11-28 | Use of bromelain for adjuvant therapy during wound healing process |
PCT/EP2001/013897 WO2002043755A1 (en) | 2000-11-28 | 2001-11-28 | Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004519433A JP2004519433A (ja) | 2004-07-02 |
JP4330878B2 true JP4330878B2 (ja) | 2009-09-16 |
Family
ID=8170509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002545725A Expired - Fee Related JP4330878B2 (ja) | 2000-11-28 | 2001-11-28 | 炎症性疾患の処置及び創傷治癒過程における補助療法のためのブロメラインの使用 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7731958B2 (ja) |
EP (2) | EP1208849B1 (ja) |
JP (1) | JP4330878B2 (ja) |
KR (1) | KR100856965B1 (ja) |
CN (1) | CN100469390C (ja) |
AU (1) | AU2002224905A1 (ja) |
BR (1) | BR0115610A (ja) |
CA (1) | CA2424483C (ja) |
WO (1) | WO2002043755A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006104080A (ja) * | 2004-10-01 | 2006-04-20 | Cross:Kk | 痛風と尿酸による血流障害の予防又は治療効果のある組成物及び健康食品。 |
IT202100015704A1 (it) * | 2021-06-16 | 2022-12-16 | Neilos S R L | “Composizione per la prevenzione e/o il trattamento di affezioni flogistiche” |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3224942A (en) * | 1962-01-15 | 1965-12-21 | Rorer Inc William H | Anti-inflammatory, anti-edema and anti-thrombi drug |
EP0421021A1 (de) * | 1989-10-06 | 1991-04-10 | MUCOS EMULSIONSGESELLSCHAFT m.b.H. | Verwendung katabolischer Enzyme zur Aktivierung von Makrophagen und/oder NK-Zellen, ein diese Enzyme enthaltendes Arzneimittel sowie durch diese Enzyme aktivierte Makrophage und/oder NK-zelle |
GB9412711D0 (en) * | 1994-06-24 | 1994-08-17 | Cortecs Ltd | Medical use of bromelain |
US5560910A (en) * | 1994-08-26 | 1996-10-01 | Crandall; Wilson T. | Topical anti-inflammatory composition and method |
-
2000
- 2000-11-28 EP EP00125986.0A patent/EP1208849B1/en not_active Expired - Lifetime
-
2001
- 2001-11-28 AU AU2002224905A patent/AU2002224905A1/en not_active Abandoned
- 2001-11-28 CA CA2424483A patent/CA2424483C/en not_active Expired - Fee Related
- 2001-11-28 CN CNB018195008A patent/CN100469390C/zh not_active Expired - Fee Related
- 2001-11-28 US US10/399,926 patent/US7731958B2/en not_active Expired - Fee Related
- 2001-11-28 JP JP2002545725A patent/JP4330878B2/ja not_active Expired - Fee Related
- 2001-11-28 KR KR1020037007115A patent/KR100856965B1/ko not_active IP Right Cessation
- 2001-11-28 BR BR0115610-1A patent/BR0115610A/pt not_active Application Discontinuation
- 2001-11-28 WO PCT/EP2001/013897 patent/WO2002043755A1/en not_active Application Discontinuation
- 2001-11-28 EP EP01994749A patent/EP1337268A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
BR0115610A (pt) | 2003-09-16 |
AU2002224905A1 (en) | 2002-06-11 |
EP1208849A1 (en) | 2002-05-29 |
EP1337268A1 (en) | 2003-08-27 |
US7731958B2 (en) | 2010-06-08 |
EP1208849B1 (en) | 2015-10-28 |
CA2424483A1 (en) | 2002-06-06 |
CA2424483C (en) | 2011-06-07 |
KR100856965B1 (ko) | 2008-09-04 |
CN1476334A (zh) | 2004-02-18 |
CN100469390C (zh) | 2009-03-18 |
JP2004519433A (ja) | 2004-07-02 |
KR20030064794A (ko) | 2003-08-02 |
WO2002043755A1 (en) | 2002-06-06 |
US20040043018A1 (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Thornhill et al. | Natural treatment of perennial allergic rhinitis | |
US10864241B2 (en) | Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract | |
EP2046345B1 (en) | Use of escin | |
KR20090079608A (ko) | 쑥추출물을 유효성분으로 함유하는 만성염증질환 치료제 | |
Boisseau | Leukocyte involvement in the signs and symptoms of chronic venous disease. Perspectives for therapy | |
KR100236454B1 (ko) | 저분자량 식물성 조성물 | |
JP4330878B2 (ja) | 炎症性疾患の処置及び創傷治癒過程における補助療法のためのブロメラインの使用 | |
EP1450835B1 (en) | Compositions for the treatment of lupus | |
KELLEY | Corticotropin (ACTH) therapy of initial attacks of acute rheumatic fever in children | |
KR20090111445A (ko) | 생맥산과 그 가감방의 피부질환의 예방 및 치료용, 또는면역증강용 약학 조성물 및 건강기능식품 | |
KR20090053055A (ko) | 평위산 및 그 가감방의 피부질환의 예방 또는 치료용,또는 면역증강용 의약 조성물 및 건강기능식품 | |
Mahalanobish et al. | Anti-inflammatory efficacy of some potentially bioactive natural products against rheumatoid arthritis | |
TWI531366B (zh) | 牛樟芝在關節炎、軟骨破壞或軟骨細胞死亡的改善或預防的功效 | |
JPH09508922A (ja) | ブロメラインの医療への適用 | |
KR20040097026A (ko) | 아토피성 피부염 예방 및 치료용 생약 조성물 및 그제조방법 | |
KR20090074295A (ko) | 지출환과 그 가감방의 피부질환의 예방 및 치료용, 또는면역증강용 약학 조성물 및 건강기능식품 | |
US20230355726A1 (en) | Fibrinolytic enzyme composition for fibrosis treatment | |
Lim | Ananas comosus | |
KR20220168960A (ko) | 감초 신품종 원감 또는 신원감을 포함하는 알레르기에 치료 및 예방에 효과있는 약제학적 조성물 및 그 치료제 | |
SU1131505A1 (ru) | Способ лечени рожи | |
Council | Category: Vitamin B | |
Kulasekharam et al. | International Journal of Medical and Health Sciences | |
Hiransai | The Mechanisms of Dioscorealide B and Dioscoreanone from the Rhizome of Dioscorea membranacea (Pierre ex Prain & Burkill) on Anti-inflammatory Activity in RAW 264.7 Macrophages | |
Collins et al. | Systemic Enzyme Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20040623 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040818 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070814 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071113 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071120 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071213 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071220 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080107 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080115 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080214 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080603 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081001 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081001 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081117 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20090310 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090602 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090617 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120626 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130626 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |